Cowen/ US2236226062 /
2023-02-28 10:00:00 PM | Chg. - | Volume | Bid1:50:03 AM | Ask1:50:03 AM | High | Low |
---|---|---|---|---|---|---|
38.9900USD | - | 983,583 Turnover: 33.42 mill. |
39.0000Bid Size: - | 39.0100Ask Size: - | 39.0100 | 38.9900 |
GlobeNewswire
2:00 PM
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
1:00 PM
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
GlobeNewswire
05-13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
05-09
CompoSecure Announces Pricing of Secondary Offering of Shares of Class A Common Stock by Selling Sha...
GlobeNewswire
05-08
CompoSecure Announces Launch of Secondary Offering of Shares of Class A Common Stock by Selling Shar...
GlobeNewswire
05-02
Tower Semiconductor to Attend the 52nd Annual TD Cowen Technology, Media & Telecom Conference
GlobeNewswire
05-01
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer a...
GlobeNewswire
04-30
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 F...
GlobeNewswire
04-30
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfoli...